Human CD133-positive hematopoietic progenitor cells enhance the malignancy of breast cancer cells

BACKGROUND: Human CD133+ hematopoietic progenitor cells (HPCs) are a specific subset of cells that can regulate tumor malignancy. However, the mechanism by which CD133+ HPCs affect the malignancy of human breast cancer has not been reported. METHODS: CD133+ HPCs were isolated and purified from human...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zhe, Zheng, Qinglian, Liu, Yonghui, Sun, Lianqing, Han, Pingping, Wang, Rui, Zhao, Jiao, Hu, Shan, Zhao, Xinhan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7690192/
https://www.ncbi.nlm.nih.gov/pubmed/33243165
http://dx.doi.org/10.1186/s12885-020-07633-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7690192/
https://www.ncbi.nlm.nih.gov/pubmed/33243165
http://dx.doi.org/10.1186/s12885-020-07633-3

Ejemplares similares